Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Ovarian Epithelial
×
olaparib
×
Clear all
Filters
3
NCT06915025
2026-04-13
OVATION-3
Imunon
Phase 3
Recruiting
500 enrolled
NCT03106987
2022-10-07
OReO
AstraZeneca
Phase 3
Completed
220 enrolled
21 charts